{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T20:37:44Z","timestamp":1783456664763,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR066712"],"award-info":[{"award-number":["AR066712"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR07534"],"award-info":[{"award-number":["AR07534"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.amjms.2023.03.003","type":"journal-article","created":{"date-parts":[[2023,3,12]],"date-time":"2023-03-12T18:37:51Z","timestamp":1678646271000},"page":"480-487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Serum antibodies to peptidylarginine deiminase-4 in rheumatoid arthritis associated-interstitial lung disease are associated with decreased lung fibrosis and improved survival"],"prefix":"10.1016","volume":"365","author":[{"given":"Timothy M.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua J.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Humphries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Swigris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faduma","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Darrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Kristen","family":"Demoruelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2 Pt 1","key":"10.1016\/j.amjms.2023.03.003_bib0001","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1164\/ajrccm.156.2.9609016","article-title":"Interstitial lung disease in recent onset rheumatoid arthritis","volume":"156","author":"Gabbay","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.amjms.2023.03.003_bib0002","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10067-010-1492-5","article-title":"Pulmonary involvement in early rheumatoid arthritis patients","volume":"30","author":"Habib","year":"2011","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.amjms.2023.03.003_bib0003","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1164\/rccm.201004-0622OC","article-title":"Rheumatoid arthritis-interstitial lung disease-associated mortality","volume":"183","author":"Olson","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.amjms.2023.03.003_bib0004","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12890-021-01569-5","article-title":"Mortality rate in rheumatoid arthritis-related interstitial lung disease: the role of radiographic patterns","volume":"21","author":"Nieto","year":"2021","journal-title":"BMC Pulm Med"},{"issue":"5","key":"10.1016\/j.amjms.2023.03.003_bib0005","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1159\/000502551","article-title":"Rheumatoid arthritis-associated interstitial lung disease: clinical characteristics and predictors of mortality","volume":"98","author":"Hyldgaard","year":"2019","journal-title":"Respiration"},{"issue":"5","key":"10.1016\/j.amjms.2023.03.003_bib0006","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1378\/chest.09-0444","article-title":"Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern","volume":"136","author":"Kim","year":"2009","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.amjms.2023.03.003_bib0007","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1183\/09031936.00092309","article-title":"Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease","volume":"35","author":"Kim","year":"2010","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.amjms.2023.03.003_bib0008","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1183\/13993003.00357-2015","article-title":"Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease","volume":"47","author":"Solomon","year":"2016","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.amjms.2023.03.003_bib0009","first-page":"280","article-title":"Rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary fibrosis: shared mechanistic and phenotypic traits suggest overlapping disease mechanisms","volume":"67","author":"Paulin","year":"2015","journal-title":"Rev Investig Clin"},{"issue":"6","key":"10.1016\/j.amjms.2023.03.003_bib0010","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.chest.2019.12.005","article-title":"IgA antibodies directed against citrullinated protein antigens are elevated in patients with idiopathic pulmonary fibrosis","volume":"157","author":"Solomon","year":"2020","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.amjms.2023.03.003_bib0011","doi-asserted-by":"crossref","first-page":"700","DOI":"10.2174\/1389450116666150202160954","article-title":"Protein arginine deiminases and associated citrullination: physiological functions and diseases associated with dysregulation","volume":"16","author":"Witalison","year":"2015","journal-title":"Curr Drug Targets"},{"issue":"6","key":"10.1016\/j.amjms.2023.03.003_bib0012","first-page":"969","article-title":"Prevalence and significance of anti-peptidylarginine deiminase 4 antibodies in rheumatoid arthritis","volume":"35","author":"Zhao","year":"2008","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.amjms.2023.03.003_bib0013","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1002\/art.23596","article-title":"Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis","volume":"58","author":"Harris","year":"2008","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.amjms.2023.03.003_bib0014","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/ard.2007.080267","article-title":"Serum IgG antibodies to peptidylarginine deiminase 4 in rheumatoid arthritis and associations with disease severity","volume":"67","author":"Halvorsen","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.amjms.2023.03.003_bib0015","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3899\/jrheum.130293","article-title":"Prevalence of anti-peptidylarginine deiminase type 4 antibodies in rheumatoid arthritis and unaffected first-degree relatives in indigenous North American Populations","volume":"40","author":"Ferucci","year":"2013","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.amjms.2023.03.003_bib0016","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s13075-016-1126-7","article-title":"Association of anti-peptidyl arginine deiminase antibodies with radiographic severity of rheumatoid arthritis in African Americans","volume":"18","author":"Navarro-Millan","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.amjms.2023.03.003_bib0017","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/art.40791","article-title":"Association of baseline peptidylarginine deiminase 4 autoantibodies with favorable response to treatment escalation in rheumatoid arthritis","volume":"71","author":"Darrah","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"186","key":"10.1016\/j.amjms.2023.03.003_bib0018","doi-asserted-by":"crossref","first-page":"186ra65","DOI":"10.1126\/scitranslmed.3005370","article-title":"Erosive rheumatoid arthritis is associated with antibodies that activate PAD4 by increasing calcium sensitivity","volume":"5","author":"Darrah","year":"2013","journal-title":"Sci Transl Med"},{"issue":"6","key":"10.1016\/j.amjms.2023.03.003_bib0019","doi-asserted-by":"crossref","first-page":"e98794","DOI":"10.1371\/journal.pone.0098794","article-title":"Association of cross-reactive antibodies targeting peptidyl-arginine deiminase 3 and 4 with rheumatoid arthritis-associated interstitial lung disease","volume":"9","author":"Giles","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.amjms.2023.03.003_bib0020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13075-021-02528-5","article-title":"Anti-peptidylarginine deiminase-4 antibodies at mucosal sites can activate peptidylarginine deiminase-4 enzyme activity in rheumatoid arthritis","volume":"23","author":"Demoruelle","year":"2021","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"10.1016\/j.amjms.2023.03.003_bib0021","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.amjms.2023.03.003_bib0022","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S2213-2600(17)30433-2","article-title":"Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper","volume":"6","author":"Lynch","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.amjms.2023.03.003_bib0023","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.amjms.2023.03.003_bib0024","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01384-2018","article-title":"Quantitative high-resolution computed tomography fibrosis score: performance characteristics in idiopathic pulmonary fibrosis","volume":"52","author":"Humphries","year":"2018","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.amjms.2023.03.003_bib0025","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1148\/radiol.2017161177","article-title":"Idiopathic pulmonary fibrosis: data-driven textural analysis of extent of fibrosis at baseline and 15-month follow-up","volume":"285","author":"Humphries","year":"2017","journal-title":"Radiology"},{"issue":"12","key":"10.1016\/j.amjms.2023.03.003_bib0026","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/thoraxjnl-2018-212430","article-title":"MUC5B variant is associated with visually and quantitatively detected preclinical pulmonary fibrosis","volume":"74","author":"Mathai","year":"2019","journal-title":"Thorax"},{"key":"10.1016\/j.amjms.2023.03.003_bib0027","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.rmed.2017.04.012","article-title":"The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease","volume":"127","author":"Morisset","year":"2017","journal-title":"Respir Med"},{"key":"10.1016\/j.amjms.2023.03.003_bib0028","article-title":"Anti-protein arginine deiminase antibodies are distinctly associated with joint and lung involvement in rheumatoid arthritis","author":"Palterer","year":"2022","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.amjms.2023.03.003_bib0029","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13075-018-1533-z","article-title":"Smoking is not linked to the development of anti-peptidylarginine deiminase 4 autoantibodies in rheumatoid arthritis","volume":"20","author":"Cappelli","year":"2018","journal-title":"Arthritis Res Ther"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962923010625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962923010625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:42:42Z","timestamp":1757702562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962923010625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0002962923010625"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2023.03.003","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum antibodies to peptidylarginine deiminase-4 in rheumatoid arthritis associated-interstitial lung disease are associated with decreased lung fibrosis and improved survival","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2023.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of Southern Society for Clinical Investigation.","name":"copyright","label":"Copyright"}]}}